Angiotensin II and Angiotensin (1-7) Induce Distinct AGTR2 Conformational Dynamics, Revealing Dual Signaling Profiles
Background
The Angiotensin II type-2 receptor (AGTR2) is a crucial G protein-coupled receptor (GPCR) within the renin-angiotensin system (RAS), mediating beneficial vasodilatory, anti-proliferative, and cardioprotective effects. Despite its therapeutic potential, the precise structural dynamics underlying its ligand-specific activation, particularly how different Angiotensin peptides modulate its function, remain incompletely understood. Elucidating these ligand-specific mechanisms is vital for fine-tuning cardiovascular responses and developing targeted therapies that leverage the protective arm of the RAS.
Study Design
Long-timescale molecular dynamics (MD) simulations were performed to investigate how Angiotensin II and Angiotensin (1-7) differentially modulate the structural dynamics of AGTR2. The simulations explored both inactive- and active-like receptor conformations to understand ligand-specific modulation within the RAS protective arm. The study analyzed key structural elements, including TM3-TM6 distances, hydrogen bonding, salt bridges, hydrophobic contacts, and rotameric locking of micro-switches, alongside activation motif analyses (CWxP, PIF, E/DRY, NPxxY), DCC maps, CP, DRIN metrics, and PCA to characterize distinct signaling features.
Results
Angiotensin II (Ang II) stabilized a 'Locked Active State' in AGTR2 through compact TM3-TM6 distances. This stabilization involved persistent hydrogen bonding (PHE8-LYS2155.42), specific salt bridges (ARG2-ASP2796.58, ARG2-ASP2977.32), and hydrophobic contacts (TRP1002.60, MET1283.36), along with rotameric locking of micro-switches. These interactions significantly stabilized Helix 8, enhancing dynamic network connectivity and supporting activation-related conformational tendencies rather than a full canonical GPCR activation. Conversely, Angiotensin (1-7) (Ang1-7) induced a 'Flexible Intermediate State' characterized by weaker interactions (PRO7-THR1253.33), dynamic instability at the Helix 8 interface, and increased conformational sampling. Activation motif analyses and various metrics (DCC maps, CP, DRIN, PCA) consistently confirmed these distinct signaling features for each ligand.
Angiotensin II acts as a strong conformational stabilizer promoting activation-related dynamic features, while Angiotensin (1-7) serves as a dynamic modulator.
Key Findings
- Angiotensin II stabilizes a 'Locked Active State' in
AGTR2via compactTM3-TM6distances and specific interactions. - Angiotensin (1-7) induces a 'Flexible Intermediate State' in
AGTR2with weaker interactions and increased conformational sampling. - Angiotensin II promotes activation-related dynamic features by stabilizing Helix 8 and enhancing network connectivity.
- Angiotensin (1-7) exhibits dynamic instability at the Helix 8 interface, leading to a more flexible receptor state.
- Computational analyses (e.g.,
DCCmaps,PCA) confirm distinct signaling profiles for each ligand.
Why It Matters
This study provides a critical structural and dynamic framework for understanding AGTR2 signaling, offering a dual functional profile for its ligands. Understanding these distinct conformational states could enable the design of novel therapeutics that selectively target specific AGTR2 activation pathways, potentially leading to more precise interventions for cardiovascular diseases. For peptide users and researchers, this highlights how subtle differences in ligand structure (Ang II vs. Ang 1-7) can lead to profoundly different receptor dynamics and downstream signaling, informing future peptide design and mechanistic studies. This mechanistic insight is a foundational step, far from a usable protocol, but crucial for rational drug discovery in the RAS.
agtr2
angiotensin-ii
angiotensin-(1-7)
renin-angiotensin-system
gpcr
molecular-dynamics